Leap Therapeutics Q3 EPS $(0.33) Up From $(0.55) YoY

Leap Therapeutics (NASDAQ:LPTX) reported quarterly losses of $(0.33) per share. This is a 40 percent increase over losses of $(0.55) per share from the same period last year.

Benzinga · 11/14/2019 12:20

Leap Therapeutics (NASDAQ:LPTX) reported quarterly losses of $(0.33) per share. This is a 40 percent increase over losses of $(0.55) per share from the same period last year.